Cargando…

NUBPL, a novel metastasis‐related gene, promotes colorectal carcinoma cell motility by inducing epithelial–mesenchymal transition

Nucleotide binding protein‐like, NUBPL, is an assembly factor for human mitochondrial complex I, which is the biggest member of the mitochondrial respiratory chain. However, the relationship between NUBPL and carcinoma progression remains unknown. In this study, NUBPL was characterized for its role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuhui, Wu, Nan, Sun, Donglin, Sun, Haiming, Tong, Dandan, Liu, Duo, Pang, Bo, Li, Su, Wei, Jia, Dai, Jialin, Liu, Yang, Bai, Jing, Geng, Jingshu, Fu, Songbin, Jin, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480060/ https://www.ncbi.nlm.nih.gov/pubmed/28346728 http://dx.doi.org/10.1111/cas.13243

Ejemplares similares

Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition
por: Wu, Nan, et al.
Publicado: (2015)

TRIB1 promotes colorectal cancer cell migration and invasion through activation MMP-2 via FAK/Src and ERK pathways
por: Wang, Yuhui, et al.
Publicado: (2017)

Loss of E-cadherin and epithelial to mesenchymal transition is not required for cell motility in tissues or for metastasis
por: Liu, Xiang, et al.
Publicado: (2014)

Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)

Loss-of-Function NUBPL Mutation May Link Parkinson's Disease to Recessive Complex I Deficiency
por: Eis, Peggy S., et al.
Publicado: (2020)

LGR5 promotes epithelial ovarian cancer proliferation, metastasis, and epithelial–mesenchymal transition through the Notch1 signaling pathway
por: Liu, Wenxue, et al.
Publicado: (2018)

High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency
por: Calvo, Sarah E, et al.
Publicado: (2010)

Pathogenic mutations in NUBPL affect complex I activity and cold tolerance in the yeast model Yarrowia lipolytica
por: Maclean, Andrew E, et al.
Publicado: (2018)

Mitochondrial complex I NUBPL mutations cause combined dystonia with bilateral striatal necrosis and cerebellar atrophy
por: Balint, B., et al.
Publicado: (2019)

Early embryonic lethality in complex I associated p.L104P Nubpl mutant mice
por: Cheng, Cheng, et al.
Publicado: (2022)

Overexpression of shugoshin1 predicts a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial–mesenchymal transition
por: Mu, Jiagui, et al.
Publicado: (2019)

Critical Roles of p53 in Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma Cells
por: Wang, Zheng, et al.
Publicado: (2013)

Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis
por: Du, Liang, et al.
Publicado: (2017)

SATB1 promotes epithelial-mesenchymal transition and metastasis in prostate cancer
por: Qi, Honggang, et al.
Publicado: (2017)

SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial‐mesenchymal transition
por: Zhang, Yuanping, et al.
Publicado: (2021)

MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis
por: Yang, Fan, et al.
Publicado: (2014)

ATP6L promotes metastasis of colorectal cancer by inducing epithelial‐mesenchymal transition
por: Wang, Jingyi, et al.
Publicado: (2020)

p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma
por: Wu, Dandan, et al.
Publicado: (2016)

Leukodystrophy Associated with Mitochondrial Complex 1 Deficiency Due to Mutation in NUBPL Gene—An Unusual Follow-Up Finding
por: Peter S, Babu, et al.
Publicado: (2022)

DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells
por: Zhang, Lili, et al.
Publicado: (2018)

Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011)

Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis
por: Campbell, Kyra
Publicado: (2018)

Epithelial-to-Mesenchymal Transition in Metastasis: Focus on Laryngeal Carcinoma
por: Goulioumis, Anastasios, et al.
Publicado: (2022)

Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells
por: Qin, Yuan, et al.
Publicado: (2015)

N-Cadherin Extracellular Repeat 4 Mediates Epithelial to Mesenchymal Transition and Increased Motility
por: Kim, Jae-Beom, et al.
Publicado: (2000)

Mesenchymal Stem Cells in Inflammation Microenvironment Accelerates Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal Transition
por: Jing, Yingying, et al.
Publicado: (2012)

CDC27 Induces Metastasis and Invasion in Colorectal Cancer via the Promotion of Epithelial-To-Mesenchymal Transition
por: Qiu, Lin, et al.
Publicado: (2017)

Glutamine deficiency promotes recurrence and metastasis in colorectal cancer through enhancing epithelial–mesenchymal transition
por: Sun, Hongyan, et al.
Publicado: (2022)

Small breast epithelial mucin promotes the invasion and metastasis of breast cancer cells via promoting epithelial-to-mesenchymal transition
por: Li, Qiu-Hua, et al.
Publicado: (2020)

Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1
por: Zhao, Xiu-lan, et al.
Publicado: (2011)

Mammalian Eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition
por: Meng, Qingwei, et al.
Publicado: (2016)

Role of IQGAP3 in metastasis and epithelial–mesenchymal transition in human hepatocellular carcinoma
por: Shi, Yongjie, et al.
Publicado: (2017)

HOXD9 promote epithelial‐mesenchymal transition and metastasis in colorectal carcinoma
por: Liu, Mengwei, et al.
Publicado: (2020)

The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis
por: Wang, Changli, et al.
Publicado: (2012)

Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
por: Qin, Ge, et al.
Publicado: (2015)

Regorafenib reverses HGF‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
por: Chen, Weibo, et al.
Publicado: (2019)

Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts
por: Tisza, Michael J., et al.
Publicado: (2016)

Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2012)

Epithelial‐mesenchymal transition in cancer metastasis through the lymphatic system
por: Karlsson, Mikael C., et al.
Publicado: (2017)

Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis
por: Pearson, Gray W.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r2vpsccag6u0u0u8uj2q4s9l17